Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury

doi:10.3748/wjg.v30.i18.2454

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2718)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

1446

Figures (1-5)

151

Tables (1-1)

165

Sum=1813

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

143

Download

293

Sum=436

Publishing Process of This Article

Item

Count

Browse

Download

323

Sum=385

May 14, 2024 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. May 14, 2024; 30(18): 2454-2466
Published online May 14, 2024. doi: 10.3748/wjg.v30.i18.2454

Full Size Figure Download Figure

Figure 5 Diagnostic value of the hub metabolites. A: Area under the receiver operating characteristic curve of hub metabolites; B: Expression of hub metabolites in both groups; C: Distance correlation matrix plots displaying the partial Spearman’s correlation among the five hub metabolites and 12 clinical indicators of drug-induced liver injury. AUC: Area under the curve.

Citation: Yu SM, Zheng HC, Wang SC, Rong WY, Li P, Jing J, He TT, Li JH, Ding X, Wang RL. Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury. World J Gastroenterol 2024; 30(18): 2454-2466
URL: https://www.wjgnet.com/1007-9327/full/v30/i18/2454.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i18.2454